US8017634B2
(en)
|
2003-12-29 |
2011-09-13 |
President And Fellows Of Harvard College |
Compositions for treating obesity and insulin resistance disorders
|
US20070014833A1
(en)
*
|
2005-03-30 |
2007-01-18 |
Sirtris Pharmaceuticals, Inc. |
Treatment of eye disorders with sirtuin modulators
|
US20060229265A1
(en)
*
|
2005-03-30 |
2006-10-12 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
US20060292099A1
(en)
*
|
2005-05-25 |
2006-12-28 |
Michael Milburn |
Treatment of eye disorders with sirtuin modulators
|
US20070149466A1
(en)
*
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
US8106184B2
(en)
|
2005-11-18 |
2012-01-31 |
Cornell University |
Nicotinoyl riboside compositions and methods of use
|
US9874501B2
(en)
|
2006-11-24 |
2018-01-23 |
Curiox Biosystems Pte Ltd. |
Use of chemically patterned substrate for liquid handling, chemical and biological reactions
|
WO2008063135A1
(en)
|
2006-11-24 |
2008-05-29 |
Agency For Science, Technology And Research |
Apparatus for processing a sample in a liquid droplet and method of using the same
|
WO2013114217A1
(en)
|
2012-02-05 |
2013-08-08 |
Curiox Biosystems Pte Ltd. |
Array plates and methods for making and using same
|
US10725020B2
(en)
*
|
2007-11-14 |
2020-07-28 |
Curiox Biosystems Pte Ltd. |
High throughput miniaturized assay system and methods
|
US20120156134A1
(en)
|
2007-12-20 |
2012-06-21 |
Shayne Squires |
Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
|
EP2313074A4
(en)
*
|
2008-06-30 |
2015-04-15 |
Elc Man Llc |
TOPICAL COMPOSITIONS CONTAINING ISONICOTINAMIDE
|
US8362277B2
(en)
|
2009-01-09 |
2013-01-29 |
Board Of Regents Of The University Of Texas System |
Pro-neurogenic compounds
|
US9162980B2
(en)
|
2009-01-09 |
2015-10-20 |
Board Of Regents Of The University Of Texas System |
Anti-depression compounds
|
CN107595841A
(zh)
|
2009-01-09 |
2018-01-19 |
得克萨斯州大学系统董事会 |
前神经原性化合物
|
WO2011081942A1
(en)
|
2009-12-14 |
2011-07-07 |
Cornell University |
Activation and activators of sirt5
|
WO2012006419A2
(en)
|
2010-07-07 |
2012-01-12 |
Board Of Regents Of The University Of Texas System |
Pro-neurogenic compounds
|
US9878328B2
(en)
|
2010-07-23 |
2018-01-30 |
Curiox Biosystems Pte Ltd. |
Apparatus and method for multiple reactions in small volumes
|
CN102000079B
(zh)
*
|
2010-09-30 |
2012-05-30 |
中国人民解放军第二军医大学 |
尼克酰胺单核苷酸磷酸核糖转移酶抑制剂的应用
|
WO2012114204A2
(en)
|
2011-02-15 |
2012-08-30 |
Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto |
Methods of treating mitochondrial dysfunction
|
US20140189897A1
(en)
|
2011-06-21 |
2014-07-03 |
Mayo Foundation For Medical Education And Research |
Transgenic animals capable of being induced to delete senescent cells
|
US20120328526A1
(en)
*
|
2011-06-27 |
2012-12-27 |
University Of Maryland, Baltimore |
Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof
|
AU2012352177A1
(en)
|
2011-12-13 |
2014-07-10 |
Buck Institute For Research On Aging |
Methods for improving medical therapies
|
US20150064137A1
(en)
|
2012-04-17 |
2015-03-05 |
Kythera Biopharmaceuticals, Inc. |
Use of engineered viruses to specifically kill senescent cells
|
US9901081B2
(en)
|
2012-08-23 |
2018-02-27 |
Buck Institute For Research On Aging |
Transgenic mouse for determining the role of senescent cells in cancer
|
US9901080B2
(en)
|
2012-08-23 |
2018-02-27 |
Buck Institute For Research On Aging |
Transgenic mouse having a transgene that converts a prodrug into a cytotoxic compound in senescent cells
|
CN102876759A
(zh)
*
|
2012-10-29 |
2013-01-16 |
尚科生物医药(上海)有限公司 |
尼克酰胺腺嘌呤二核苷酸的制备方法
|
CN103233051B
(zh)
*
|
2012-12-19 |
2016-01-27 |
浙江嘉华化工有限公司 |
一种化学生物合成法规模化制备尼克酰胺腺嘌呤二核苷酸的方法
|
US9557318B2
(en)
|
2013-07-09 |
2017-01-31 |
Curiox Biosystems Pte Ltd. |
Array plates for washing samples
|
DE202013006354U1
(de)
*
|
2013-07-15 |
2014-10-20 |
Marianne Brøndlund |
Stoffgemisch zur Behandlung von Koagulopathien
|
GB201313465D0
(en)
*
|
2013-07-29 |
2013-09-11 |
Queens University Of The Belfast |
Methods of preparing nicotinamide riboside and derivatives thereof
|
KR20160067195A
(ko)
*
|
2013-10-30 |
2016-06-13 |
크로마덱스 아이엔씨. |
피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물
|
EP3068388A4
(en)
|
2013-11-11 |
2017-04-12 |
Board of Regents of the University of Texas System |
Neuroprotective compounds and use thereof
|
WO2015070237A1
(en)
|
2013-11-11 |
2015-05-14 |
Board Of Regents Of The University Of Texas System |
Neuroprotective chemicals and methods for identifying and using same
|
US20160279161A1
(en)
*
|
2013-11-14 |
2016-09-29 |
Newsouth Innovation Pty Limited |
Senescence and senescence associated secretory phenotype
|
CA2951287A1
(en)
*
|
2014-06-06 |
2015-12-10 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof
|
PL3670522T3
(pl)
|
2014-07-24 |
2022-02-21 |
W.R. Grace & Co. - Conn. |
Krystaliczna postać chlorku rybozydu nikotynamidu
|
EP2979706A1
(en)
*
|
2014-07-30 |
2016-02-03 |
Fundación Centro Nacional De Investigaciones Oncológicas Carlos III |
Methods for treating liver or pancreatic cancer
|
CN104352513B
(zh)
*
|
2014-11-14 |
2017-04-05 |
邦泰生物工程(深圳)有限公司 |
Nadh或盐在制备治疗苯丙酮尿症药物或保健品的应用
|
EP3256137B1
(en)
*
|
2015-02-10 |
2019-11-13 |
Duke University |
Method of treating heart failure
|
CN104622886A
(zh)
*
|
2015-03-05 |
2015-05-20 |
中国人民解放军第二军医大学 |
烟酰胺核糖在制备治疗非酒精性脂肪性肝炎的药物中的应用
|
KR102629310B1
(ko)
*
|
2015-03-09 |
2024-01-24 |
더블유.알. 그레이스 앤드 캄파니-콘. |
니코틴아미드 리보사이드의 결정 형태
|
WO2016149395A1
(en)
|
2015-03-16 |
2016-09-22 |
ChromaDex Inc. |
Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof
|
CN104771330A
(zh)
*
|
2015-03-16 |
2015-07-15 |
邦泰生物工程(深圳)有限公司 |
一种含烟酰胺单核苷酸抗衰老美容护肤品组合物
|
DK3288637T3
(da)
|
2015-04-28 |
2022-10-17 |
Newsouth Innovations Pty Ltd |
Målretning af nad+ til behandling af kemoterapi- og radioterapi-induceret, kognitiv funktionsnedsættelse, neuropatier og inaktivitet
|
JP2018515485A
(ja)
|
2015-05-01 |
2018-06-14 |
ザ プロクター アンド ギャンブル カンパニー |
皮膚の外観を改善する方法及びニコチンアミドリボシドを使用したそのための組成物
|
JP6611099B2
(ja)
*
|
2015-05-01 |
2019-11-27 |
ザ プロクター アンド ギャンブル カンパニー |
皮膚の健康を改善する方法及びそのための組成物
|
JP2018515486A
(ja)
|
2015-05-01 |
2018-06-14 |
ザ プロクター アンド ギャンブル カンパニー |
ニコチンアミドリボシドを用いた皮膚外観の改善方法及びそのための組成物
|
US10123985B2
(en)
|
2015-06-08 |
2018-11-13 |
Whitehead Institute For Biomedical Research |
Therapeutic strategies for treating mitochondrial disorders
|
AU2016274126A1
(en)
|
2015-06-10 |
2018-01-18 |
Elysium Health, Inc. |
Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders
|
US10545139B2
(en)
|
2015-06-16 |
2020-01-28 |
Curiox Biosystems Pte Ltd. |
Methods and devices for performing biological assays using magnetic components
|
US20160374908A1
(en)
|
2015-06-29 |
2016-12-29 |
The Procter & Gamble Company |
Skin care composition and methods of using the same
|
WO2017004102A1
(en)
|
2015-06-29 |
2017-01-05 |
The Procter & Gamble Company |
Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container
|
US20160374918A1
(en)
|
2015-06-29 |
2016-12-29 |
The Procter & Gamble Company |
Encapsulated skin care agent
|
EP3322419A4
(en)
*
|
2015-07-15 |
2018-08-01 |
Cornell University |
Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
|
JP6949002B6
(ja)
|
2015-08-05 |
2021-11-17 |
メトロ インターナショナル バイオテック,エルエルシー |
ニコチンアミドモノヌクレオチド誘導体及びそれらの使用
|
SG11201802933YA
(en)
*
|
2015-10-07 |
2018-05-30 |
Joel Huizenga |
Resetting biological pathways for defending against and repairing deterioration from human aging
|
SG11201803045WA
(en)
|
2015-10-29 |
2018-05-30 |
Glaxosmithkline Consumer Healthcare Holdings Us Llc |
Novel occlusive compositions
|
US10611790B2
(en)
|
2015-11-02 |
2020-04-07 |
Mitobridge, Inc. |
Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
|
US20170165282A1
(en)
*
|
2015-12-11 |
2017-06-15 |
Bontac Bio-Engineering (Shenzhen) Co., Ltd. |
Use of beta-nicotinamide mononucleotide in preparation of drugs for preventing and treating arteriosclerosis and cardio-cerebrovascular diseases, and drugs containing the same
|
WO2016188092A1
(zh)
*
|
2015-12-11 |
2016-12-01 |
邦泰生物工程(深圳)有限公司 |
烟酰胺单核苷酸在制备防治动脉硬化、心脑血管疾病的保健品中的应用及其保健品
|
WO2017109195A1
(en)
*
|
2015-12-24 |
2017-06-29 |
Amazentis Sa |
Compositions comprising nicotinamide riboside and a urolithin
|
CA3010730C
(en)
|
2016-01-11 |
2021-02-16 |
The Procter & Gamble Company |
Method of treating a skin condition and compositions therefor
|
US11116784B2
(en)
*
|
2016-02-26 |
2021-09-14 |
Beth Israel Deaconess Medical Center, Inc. |
Niacinamide (NAM) in ischemic tissue injury
|
CA3017254C
(en)
*
|
2016-03-16 |
2023-08-22 |
ChromaDex Inc. |
B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
|
WO2017158135A1
(en)
*
|
2016-03-16 |
2017-09-21 |
Dsm Ip Assets B.V. |
Microbial production of nicotinic acid riboside
|
WO2017158132A1
(en)
*
|
2016-03-16 |
2017-09-21 |
Dsm Ip Assets B.V. |
Microbial production of nicotinic acid riboside
|
AU2017246334C1
(en)
*
|
2016-04-04 |
2022-11-17 |
Sinopia Biosciences, Inc. |
Treating extrapyramidal syndrome using Trapidil
|
CN109562104A
(zh)
*
|
2016-04-14 |
2019-04-02 |
可劳迈戴斯有限公司 |
烟酰胺核苷、烟酸核苷、烟酰胺单核苷酸、和烟碱基化合物衍生物在婴儿配方中的用途
|
CN109640984A
(zh)
|
2016-04-20 |
2019-04-16 |
可劳迈戴斯有限公司 |
烟酸核苷或烟酰胺核苷衍生物及其还原的衍生物作为增加nad+的前体的用途
|
WO2017218580A1
(en)
|
2016-06-14 |
2017-12-21 |
Rejuvenation Therapeutics Corporation |
Synthetic methods for the preparation of nicotinamide riboside and related compounds
|
GB2553001A
(en)
*
|
2016-08-19 |
2018-02-21 |
The Queen's Univ Of Belfast |
Lactone intermediates of nicotinamide riboside and nicotinate riboside
|
NZ753674A
(en)
|
2016-11-11 |
2024-01-26 |
Chromadex Inc |
Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
US11633421B2
(en)
|
2016-11-29 |
2023-04-25 |
University Of Iowa Research Foundation |
Use of NAD precursors for improving maternal health and/or offspring health
|
WO2018129039A1
(en)
|
2017-01-04 |
2018-07-12 |
President And Fellows Of Harvard College |
Modulating nudix homology domain (nhd) with nicotinamide mononucleotide analogs and derivatives of same
|
WO2018132833A1
(en)
*
|
2017-01-13 |
2018-07-19 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods for treating hypertension and arterial stiffness
|
US10376528B2
(en)
|
2017-03-10 |
2019-08-13 |
Tecton Group, Llc |
Composition comprising ketone body and nicotinamide adenine dinucleotide modulator and methyl donor
|
WO2018185554A1
(en)
|
2017-04-05 |
2018-10-11 |
Curiox Biosystems Pte Ltd. |
Methods, devices, and apparatus for washing samples on array plates
|
SI3606929T1
(sl)
*
|
2017-04-05 |
2021-11-30 |
Cornell University |
Nukleotidi beta-nikotinat estra in postopki za pripravo le-teh
|
SG11201912267SA
(en)
*
|
2017-06-19 |
2020-01-30 |
Gangadhara Ganapati |
Nicotinamide riboside derivatives and their uses
|
JP6997222B2
(ja)
|
2017-06-23 |
2022-01-17 |
ザ プロクター アンド ギャンブル カンパニー |
皮膚の外観を改善するための組成物及び方法
|
CN107536844A
(zh)
*
|
2017-06-30 |
2018-01-05 |
上海风劲生物医药科技有限公司 |
烟酰胺单核苷酸在制备预防或治疗rtPA血管并发症的药物中的应用
|
JP2020526511A
(ja)
|
2017-06-30 |
2020-08-31 |
エリジウム・ヘルス・インコーポレイテッド |
ニコチンアミドリボシドの合成方法
|
WO2019122084A1
(en)
|
2017-12-22 |
2019-06-27 |
Stemtek Therapeutics, S.L. |
Process for the preparation of nicotinamide riboside chloride derivatives
|
WO2019126482A1
(en)
|
2017-12-22 |
2019-06-27 |
Elysium Health, Inc. |
Crystalline forms of nicotinamide riboside chloride
|
WO2019221813A1
(en)
*
|
2018-05-15 |
2019-11-21 |
Jumpstart Fertility Pty Ltd |
Inorganic salts of nicotinic acid mononucleotide as anti-aging agents
|
JP2021530447A
(ja)
|
2018-07-03 |
2021-11-11 |
ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company |
皮膚状態の治療方法
|
CN108949677B
(zh)
*
|
2018-07-05 |
2021-11-30 |
浙江大学 |
地黄苷c和丹酚酸a在促进体外培养骨髓间充质干细胞增殖和抑制复制性衰老中的应用
|
CN109053838A
(zh)
*
|
2018-07-26 |
2018-12-21 |
四川大学 |
制备β-烟酰胺单核苷酸或β-烟酰胺核糖的方法
|
EP3855943A2
(en)
|
2018-09-27 |
2021-08-04 |
Société des Produits Nestlé S.A. |
Compositions and methods using at least one glycine or derivative thereof, at least one n-acetylcysteine or derivative thereof, and at least one nicotinamide riboside or nad+ precursor
|
US20210388018A1
(en)
*
|
2018-10-01 |
2021-12-16 |
Cornell University |
Methyl and ethyl nicotinate-riboside-5-phosphates, preparation thereof and methods of use thereof
|
EP3897666A2
(en)
*
|
2018-12-17 |
2021-10-27 |
Mitopower LLC |
Nicotinyl riboside compounds and their uses
|
US20220125814A1
(en)
*
|
2019-03-21 |
2022-04-28 |
Fred Hutchinson Cancer Research Center |
Cancer combination therapies utilizing a nicotinamide phosphoribosyltransferase inhibitor in combination with a nicotinamide adenine dinucleotide salvage pathway precursor
|
AU2020318679A1
(en)
|
2019-07-19 |
2022-02-24 |
Biosynth Ag |
Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof
|
JP2022544776A
(ja)
*
|
2019-08-14 |
2022-10-21 |
メトロ インターナショナル バイオテック,エルエルシー |
ニコチンアミドアデニンジヌクレオチドの差次的モジュレーションのための化合物及び組成物
|
KR102315139B1
(ko)
*
|
2019-12-17 |
2021-10-20 |
주식회사 휴메딕스 |
지방아민 컨쥬게이션된 니코틴아미드 리보사이드 유도체
|
CN111153953A
(zh)
*
|
2020-01-07 |
2020-05-15 |
杭州洁汉化工有限公司 |
一种烟酰胺核糖氯化物的高效合成方法
|
CN111253448B
(zh)
*
|
2020-03-04 |
2021-09-21 |
上海昶法新材料有限公司 |
一种β-烟酰胺单核苷酸的制备方法和纯化方法
|
US20230346818A1
(en)
|
2020-04-01 |
2023-11-02 |
Societe Des Produits Nestle S.A. |
Compositions and methods containing n-acetylcystein and nicotinamide riboside for prevention and treatment of neurological diseases and conditions
|
US10959933B1
(en)
|
2020-06-01 |
2021-03-30 |
The Procter & Gamble Company |
Low pH skin care composition and methods of using the same
|
JP2023528616A
(ja)
|
2020-06-01 |
2023-07-05 |
ザ プロクター アンド ギャンブル カンパニー |
ビタミンb3化合物の皮膚への浸透を改善する方法
|
CN111632049A
(zh)
*
|
2020-06-09 |
2020-09-08 |
西北农林科技大学 |
一种通过综合矫正细胞活性氧簇代谢紊乱以缓解睾丸衰老损伤的复合配方
|
CN111763235A
(zh)
*
|
2020-06-29 |
2020-10-13 |
上海舒泽生物科技研究所 |
一种烟酰胺核糖的合成方法
|
CN111973614A
(zh)
*
|
2020-07-28 |
2020-11-24 |
南华大学 |
烟酰胺单核苷酸在制备预防、改善和/或治疗囊卵巢综合症的药物中的应用
|
WO2022047182A1
(en)
*
|
2020-08-28 |
2022-03-03 |
University Of Washington |
High dose nicotinamide adenine dinucleotide (nad) precursor regimens for reduction of inflammation in human patients with preexisting inflammation
|
JP2023548905A
(ja)
|
2020-11-18 |
2023-11-21 |
ソシエテ・デ・プロデュイ・ネスレ・エス・アー |
細胞エネルギーのための、オレウロペイン及びニコチンアミドリボシドの組み合わせを使用する組成物及び方法
|
CN112851730B
(zh)
*
|
2021-01-08 |
2023-02-21 |
厦门瑞林药业有限公司 |
一种nmn中间体nr氯化物合成方法
|
WO2022233923A1
(en)
|
2021-05-04 |
2022-11-10 |
Bohan & Co As. |
A process for synthesis of nicotinamide riboside chloride (nrcl)
|
WO2023147161A2
(en)
*
|
2022-01-31 |
2023-08-03 |
New Frontier Bio, Inc. |
Nicotinate and nicotinamide riboside-based compounds and derivatives thereof
|
WO2023150072A1
(en)
|
2022-02-01 |
2023-08-10 |
Sinclair David A |
Compositions and methods for the preservation of plant matter
|